Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Pilot Outreach Program in Remedis-The Promising Step toward HCV Elimination among People Who Inject Drugs

L. Krekulová, T. Damajka, Z. Krumphanslová, V. Řehák

. 2022 ; 20 (1) : . [pub] 20221228

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004874

The global effort to eliminate HCV infection requires new approaches to accessing and testing the affected population in a setting with as low of a threshold as possible. The focus should be on socially marginalized people who inject drugs (PWIDs) and who are not willing or able to visit standard medical services. With this vision, we established an outreach service-a testing point in an ambulance in the park in front of the Main Railway Station of the capital city of Prague-to provide bloodborne disease testing and treatment. The service was available every week on Wednesday afternoon. Over the initial two years of our experience, 168 unique people were tested. Of them, 82 (49%) were diagnosed with chronic HCV infection and were eligible for treatment with antivirals. Of these, 24 (29%) initiated antiviral treatment over the study period, and 17 (71%) of these individuals achieved a documented sustained virological response. Offering medical services in PWIDs' neighborhoods helps overcome barriers and increase the chances that they will become patients and begin HCV treatment. The described outcomes appear promising for reaching the vision of linkage to the care of such a hard-to-reach population and can serve as a feasible model of care for further expansion.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004874
003      
CZ-PrNML
005      
20230425171754.0
007      
ta
008      
230418s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijerph20010501 $2 doi
035    __
$a (PubMed)36612821
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Krekulová, Laura $u Remedis, s.r.o., Vladimírova 10, 140 00 Prague 4, Czech Republic $u 4th Department of Internal Medicine, First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 128 00 Prague 2, Czech Republic $1 https://orcid.org/0000000237719663 $7 jn20000919542
245    10
$a Pilot Outreach Program in Remedis-The Promising Step toward HCV Elimination among People Who Inject Drugs / $c L. Krekulová, T. Damajka, Z. Krumphanslová, V. Řehák
520    9_
$a The global effort to eliminate HCV infection requires new approaches to accessing and testing the affected population in a setting with as low of a threshold as possible. The focus should be on socially marginalized people who inject drugs (PWIDs) and who are not willing or able to visit standard medical services. With this vision, we established an outreach service-a testing point in an ambulance in the park in front of the Main Railway Station of the capital city of Prague-to provide bloodborne disease testing and treatment. The service was available every week on Wednesday afternoon. Over the initial two years of our experience, 168 unique people were tested. Of them, 82 (49%) were diagnosed with chronic HCV infection and were eligible for treatment with antivirals. Of these, 24 (29%) initiated antiviral treatment over the study period, and 17 (71%) of these individuals achieved a documented sustained virological response. Offering medical services in PWIDs' neighborhoods helps overcome barriers and increase the chances that they will become patients and begin HCV treatment. The described outcomes appear promising for reaching the vision of linkage to the care of such a hard-to-reach population and can serve as a feasible model of care for further expansion.
650    _2
$a lidé $7 D006801
650    12
$a uživatelé drog $7 D055030
650    12
$a intravenózní abúzus drog $x epidemiologie $7 D015819
650    12
$a hepatitida C $x farmakoterapie $x epidemiologie $x prevence a kontrola $7 D006526
650    _2
$a antivirové látky $x terapeutické užití $7 D000998
650    _2
$a Hepacivirus $7 D016174
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Damajka, Tomáš $u Remedis, s.r.o., Vladimírova 10, 140 00 Prague 4, Czech Republic
700    1_
$a Krumphanslová, Zuzana $u Remedis, s.r.o., Vladimírova 10, 140 00 Prague 4, Czech Republic
700    1_
$a Řehák, Vratislav $u Remedis, s.r.o., Vladimírova 10, 140 00 Prague 4, Czech Republic
773    0_
$w MED00176090 $t International journal of environmental research and public health $x 1660-4601 $g Roč. 20, č. 1 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36612821 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425171751 $b ABA008
999    __
$a ok $b bmc $g 1925145 $s 1191083
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 20 $c 1 $e 20221228 $i 1660-4601 $m International journal of environmental research and public health $n Int. j. environ. res. public health $x MED00176090
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...